New HIV/AIDS Findings from University of Pennsylvania Described (Role of Dolutegravir/lamivudine In the Management of Pregnant People Living With Hiv-1: a Narrative Review).

MLA

“New HIV/AIDS Findings from University of Pennsylvania Described (Role of Dolutegravir/Lamivudine In the Management of Pregnant People Living With Hiv-1: A Narrative Review).” AIDS Weekly, Jan. 2025, p. 89. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=182009639&authtype=sso&custid=ns315887.

APA

New HIV/AIDS Findings from University of Pennsylvania Described (Role of Dolutegravir/lamivudine In the Management of Pregnant People Living With Hiv-1: a Narrative Review). (2025). AIDS Weekly, 89.

Chicago

“New HIV/AIDS Findings from University of Pennsylvania Described (Role of Dolutegravir/Lamivudine In the Management of Pregnant People Living With Hiv-1: A Narrative Review).” 2025. AIDS Weekly, January, 89. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=182009639&authtype=sso&custid=ns315887.